Palantir At $130: Buy, Sell or Hold

Palantir reported Q4 2025 revenue of $1.407B, up 70% year over year, with adjusted EPS of $0.25 beating the $0.18 estimate and U.S. commercial revenue surging 137% to $507M. Despite strong fundamentals and full-year 2026 revenue guidance of $7.182B-$7.198B, the stock remains a Hold at $130 because it still trades at 203x earnings amid recent insider selling and a sharp pullback from $198. Analysts’ average target is $185.25, but near-term price action likely depends on the May earnings report and whether guidance proves conservative.

Analysis

The setup is less about whether the business is high quality and more about whether the market can tolerate a software compounder trading like a long-duration asset while rates, factor crowding, and AI spend rotation remain unstable. PLTR’s real edge is not just revenue growth; it is the increasing credibility of its platform as a control layer for enterprise AI workflows, which can pull spend away from point solutions, consultants, and internal data engineering teams. That creates a winner-take-most dynamic in certain accounts, but it also raises the bar for competitors that sell “AI enablement” without owning the operational layer.

The first-order risk is valuation compression, but the second-order risk is multiple fragility if the company keeps scaling through stock-based compensation. If revenue keeps compounding but share count expansion persists, the market may begin treating growth as partially manufactured, which limits multiple expansion even on strong prints. In that regime, the stock can underperform both the index and other AI beneficiaries that monetize hardware or infrastructure more directly.

Catalyst timing matters: the next earnings event is the key inflection over days to weeks, while the larger debate is whether U.S. commercial demand can sustain 100%+ growth for another 2-3 quarters. If guidance merely confirms, the stock likely stays trapped in a high-volatility range as de-risking from momentum funds offsets fundamental buying. A true re-rating requires either evidence that current growth is under-earning the guidance range or a macro regime shift that lowers the discount rate applied to mega-multiple software.

The contrarian miss is that a sharp drawdown does not automatically make this cheaper in economic terms; it may instead be the market testing where “excellent” stops mattering if duration risk stays elevated. Under that lens, the cleanest expression is not outright long exposure, but buying optionality into the print or pairing PLTR against lower-quality AI names that lack comparable growth or cash generation. The stock is attractive only if you believe the company can keep outrunning both fundamentals skepticism and multiple compression simultaneously.

Key Decisions for Investors

• Avoid initiating a full-sized outright long in PLTR before earnings; wait for the print and only add if revenue/guidance surprise positively by enough to force upward estimate revisions, since the stock can stay range-bound despite strong execution.
• For traders with a bullish view, buy upside call spreads in PLTR into the earnings window rather than stock; the risk/reward is better because implied volatility should already reflect a large move and the downside is capped.
• Pair trade: long PLTR / short a basket of weaker AI application names with inferior growth or cash flow profiles over the next 1-2 quarters; if the AI trade rotates, capital should favor the names with real operating leverage and commercialization evidence.
• If holding PLTR long-term, hedge with short-dated puts into earnings or macro events; the 1-3 month risk is multiple compression, not business deterioration.
• For fundamental investors, require evidence of SBC moderation and continued U.S. commercial acceleration before upgrading from neutral; without that, any upside is likely to be volatile and valuation-constrained.